Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.

Galpern, Wendy R; Corrigan-Curay, Jacqueline; Lang, Anthony E; Kahn, Jeffrey; Tagle, Danilo; Barker, Roger A; Freeman, Thomas B; Goetz, Christopher G; Kieburtz, Karl; Kim, Scott Y H; Piantadosi, Steven; Comstock Rick, Amy; Federoff, Howard J

Galpern, Wendy R; Corrigan-Curay, Jacqueline; Lang, Anthony E; Kahn, Jeffrey; Tagle, Danilo; Barker, Roger A; Freeman, Thomas B; Goetz, Christopher G; Kieburtz, Karl; Kim, Scott Y H; Piantadosi, Steven; Comstock Rick, Amy; Federoff, Howard J.

Affiliation

Galpern WR; Office of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd, #2225, Bethesda, MD 20892, USA. galpernw@ninds.nih.gov

Lancet Neurol ; 11(7): 643-50, 2012 Jul.

Article in En | MEDLINE | ID: mdl-22710757

Subject(s)

Clinical Trials as Topic/ethics; Neurodegenerative Diseases/therapy; Neurosurgical Procedures/ethics; Nontherapeutic Human Experimentation/ethics; Placebos; Humans

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placebos / Clinical Trials as Topic / Neurodegenerative Diseases / Neurosurgical Procedures / Nontherapeutic Human Experimentation Type of study: Clinical_trials Aspects: Ethics Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google